Marie-Pierre Dubé

All Stories

1. 
   A Genome-Wide Association Study of Oxypurinol Concentrations in Patients Treated with Allopurinol

   Article • Journal of Personalized Medicine, June 2024, MDPI AG

   Marie-Pierre Dubé

2. 
   Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

3. 
   Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

4. 
   Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

5. 
   Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

6. 
   Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

7. 
   Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

8. 
   Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

9. 
   Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

   Article • May 2024, American Association for Cancer Research (AACR)

   Marie-Pierre Dubé

10. 
    Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

11. 
    Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

12. 
    Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

13. 
    Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

14. 
    Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

15. 
    Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

16. 
    Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

17. 
    Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

18. 
    Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

19. 
    Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

20. 
    Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

21. 
    Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

22. 
    Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

23. 
    Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

24. 
    Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

25. 
    Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

26. 
    Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

27. 
    Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

28. 
    Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

29. 
    Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

30. 
    Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

31. 
    Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

32. 
    Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

33. 
    Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

34. 
    Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

35. 
    Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

36. 
    Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

37. 
    Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

38. 
    Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

39. 
    Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

40. 
    Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

41. 
    Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

42. 
    Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

43. 
    Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

44. 
    Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

45. 
    Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

46. 
    Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

47. 
    Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

48. 
    Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

49. 
    Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

50. 
    Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

51. 
    Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

52. 
    Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

53. 
    Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

54. 
    Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

55. 
    Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

56. 
    Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

57. 
    Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

58. 
    Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

59. 
    Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

60. 
    Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

61. 
    Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

62. 
    Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

63. 
    Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

64. 
    Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

65. 
    Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

66. 
    Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

67. 
    Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

68. 
    Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

69. 
    Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

70. 
    Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

71. 
    Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

72. 
    Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

73. 
    Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

74. 
    Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

75. 
    Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

76. 
    Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

77. 
    Assessing the role of rare pathogenic variants in heart failure progression by exome sequencing in 8,089 patients

    Article • August 2023, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

78. 
    Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals

    Article • Blood Advances, July 2023, American Society of Hematology

    Marie-Pierre Dubé

79. 
    Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

80. 
    Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

81. 
    Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

82. 
    Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

83. 
    Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

84. 
    Figure 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

85. 
    Figure 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

86. 
    Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

87. 
    Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

88. 
    Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

89. 
    Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

90. 
    Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

91. 
    Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

92. 
    Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

93. 
    Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

94. 
    Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

95. 
    Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

96. 
    Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

97. 
    Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

98. 
    Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

99. 
    Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

100. 
     Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

101. 
     Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

102. 
     Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

103. 
     Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

104. 
     Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

105. 
     Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

106. 
     Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

107. 
     Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

108. 
     Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

109. 
     Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

110. 
     Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

111. 
     Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

112. 
     Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

113. 
     Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

114. 
     Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

115. 
     Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

116. 
     Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

117. 
     Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

118. 
     Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

119. 
     Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

120. 
     Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

121. 
     Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

122. 
     Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

123. 
     Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • June 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

124. 
     Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

125. 
     Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

126. 
     Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

127. 
     Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

128. 
     Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

129. 
     Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

130. 
     Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

131. 
     Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

132. 
     Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

133. 
     Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

134. 
     Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

135. 
     Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

136. 
     Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

137. 
     Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

138. 
     Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

139. 
     Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

140. 
     Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

141. 
     Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

142. 
     Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

143. 
     Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

144. 
     Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

145. 
     Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

146. 
     Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

147. 
     Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

148. 
     Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

149. 
     Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

150. 
     Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

151. 
     Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

152. 
     Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

153. 
     Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

154. 
     Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

155. 
     Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

156. 
     Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

157. 
     Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

158. 
     Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

159. 
     Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

160. 
     Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • April 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

161. 
     Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

     Article • Cancer Epidemiology Biomarkers & Prevention, March 2023, American Association for Cancer Research (AACR)

     Marie-Pierre Dubé

162. 
     Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome

     Article • European Heart Journal, November 2022, Oxford University Press (OUP)

     Marie-Pierre Dubé

163. 
     Abstract 10075: Hematopoietic Mosaic Chromosomal Alterations and Cardiovascular Disease-Related Deaths Among Cancer Survivors: An Analysis of the UK Biobank

     Article • Circulation, November 2022, Wolters Kluwer Health

     Marie-Pierre Dubé

164. 
     Including diverse and admixed populations in genetic epidemiology research

     Article • Genetic Epidemiology, July 2022, Wiley

     Marie-Pierre Dubé

165. 
     An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites

     Article • Clinical and Translational Science, June 2022, Wiley

     Marie-Pierre Dubé

166. 
     Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19

     Article • International Journal of Infectious Diseases, March 2022, Elsevier

     Marie-Pierre Dubé

167. 
     Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study

     Article • Clinical and Translational Science, February 2022, Wiley

     Marie-Pierre Dubé

168. 
     Gender matters in heart attack prevention: higher femininity linked to angina diagnosis in men

     Article • Scientific Reports, February 2022, Springer Science + Business Media

     Marie-Pierre Dubé

169. 
     Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation

     Article • Frontiers in Pharmacology, January 2022, Frontiers

     Marie-Pierre Dubé

170. 
     A sex-specific evolutionary interaction between ADCY9 and CETP

     Article • eLife, October 2021, eLife

     Marie-Pierre Dubé

171. 
     Pharmacogenomic study of heart failure and candesartan response from the CHARM programme

     Article • September 2021, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

172. 
     The genomics of heart failure: design and rationale of the HERMES consortium

     Article • ESC Heart Failure, September 2021, Wiley

     Professor John GF Cleland, Marie-Pierre Dubé

173. 
     Multitrait GWAS to connect disease variants and biological mechanisms

     Article • PLoS Genetics, August 2021, PLOS

     Marie-Pierre Dubé

174. 
     Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

     Article • The Lancet Respiratory Medicine, August 2021, Elsevier

     Marie-Pierre Dubé

175. 
     Genetics of symptom remission in outpatients with COVID-19

     Article • Scientific Reports, May 2021, Springer Science + Business Media

     Marie-Pierre Dubé

176. 
     A sex-specific evolutionary interaction betweenADCY9andCETP

     Article • May 2021, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

177. 
     Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

     Article • Canadian Journal of Cardiology, May 2021, Elsevier

     Marie-Pierre Dubé

178. 
     Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT

     Article • Circulation Genomic and Precision Medicine, April 2021, Wolters Kluwer Health

     Marie-Pierre Dubé

179. 
     Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib

     Article • Circulation Genomic and Precision Medicine, April 2021, Wolters Kluwer Health

     Marie-Pierre Dubé

180. 
     Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

     Article • European Heart Journal, March 2021, Oxford University Press (OUP)

     Marie-Pierre Dubé

181. 
     ExPheWas: a browser for gene-based pheWAS associations

     Article • March 2021, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

182. 
     Genetics of symptom remission in outpatients with COVID-19

     Article • March 2021, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

183. 
     Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women

     Article • The Pharmacogenomics Journal, March 2021, Springer Science + Business Media

     Marie-Pierre Dubé

184. 
     Comparative effectiveness and safety of high‐dose rivaroxaban and apixaban for atrial fibrillation: A propensity score‐matched cohort study

     Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2021, Wiley

     Marie-Pierre Dubé

185. 
     Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

     Article • Nature Genetics, January 2021, Springer Science + Business Media

     Marie-Pierre Dubé

186. 
     The associations of hostility and defensiveness with telomere length are influenced by sex and health status

     Article • Biology of Sex Differences, January 2021, Springer Science + Business Media

     Marie-Pierre Dubé

187. 
     A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy

     Article • ESC Heart Failure, September 2020, Wiley

     Marie-Pierre Dubé

188. 
     Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

     Article • European Heart Journal, August 2020, Oxford University Press (OUP)

     Marie-Pierre Dubé

189. 
     Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure

     Article • Clinical and Translational Science, August 2020, Wiley

     Marie-Pierre Dubé

190. 
     Statin Initiation: Guideline Concordance and Characteristics of New Users in Quebec, Canada

     Article • Journal of Population Therapeutics and Clinical Pharmacology, August 2020, Codon Publications

     Marie-Pierre Dubé

191. 
     A genetic model of ivabradine recapitulates results from randomized clinical trials

     Article • PLoS ONE, July 2020, PLOS

     Marie-Pierre Dubé

192. 
     Multitrait genetic-phenotype associations to connect disease variants and biological mechanisms

     Article • June 2020, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

193. 
     High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential

     Article • Blood Advances, June 2020, American Society of Hematology

     Marie-Pierre Dubé

194. 
     Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

     Article • European Heart Journal - Quality of Care and Clinical Outcomes, May 2020, Oxford University Press (OUP)

     Marie-Pierre Dubé

195. 
     CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta‐analysis

     Article • British Journal of Clinical Pharmacology, April 2020, Wiley

     Marie-Pierre Dubé

196. 
     Heritability of 596 lipid species and genetic correlation with cardiovascular traits in the Busselton Family Heart Study

     Article • Journal of Lipid Research, April 2020, Elsevier

     Marie-Pierre Dubé

197. 
     Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA‐HF trial

     Article • European Journal of Heart Failure, April 2020, Wiley

     Marie-Pierre Dubé

198. 
     Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

     Article • American Heart Journal, April 2020, Elsevier

     Marie-Pierre Dubé

199. 
     Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2019, New England Journal of Medicine (NEJM/MMS)

     Marie-Pierre Dubé

200. 
     Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation

     Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2019, Wiley

     Marie-Pierre Dubé

201. 
     Inherited Chromosomally Integrated Human Herpesvirus 6 Demonstrates Tissue-Specific RNA Expression In Vivo That Correlates with an Increased Antibody Immune Response

     Article • Journal of Virology, December 2019, ASM Journals

     Marie-Pierre Dubé

202. 
     Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes

     Article • The American Journal of Cardiology, December 2019, Elsevier

     Marie-Pierre Dubé

203. 
     rs73185306 C/T Is Not a Predisposing Risk Factor for Inherited Chromosomally Integrated Human Herpesvirus 6A/B

     Article • The Journal of Infectious Diseases, October 2019, Oxford University Press (OUP)

     Marie-Pierre Dubé

204. 
     Inherited chromosomally integrated HHV-6 demonstrates tissue-specific RNA expressionin vivothat correlates with increased antibody immune response

     Article • August 2019, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

205. 
     Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

     Article • Nature Genetics, June 2019, Springer Science + Business Media

     Marie-Pierre Dubé

206. 
     Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians

     Article • Circulation Genomic and Precision Medicine, June 2019, Wolters Kluwer Health

     Marie-Pierre Dubé

207. 
     Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

     Article • Circulation Genomic and Precision Medicine, April 2019, Wolters Kluwer Health

     Professor Marek Sanak, Marie-Pierre Dubé

208. 
     Subsequent Event Risk in Individuals With Established Coronary Heart Disease

     Article • Circulation Genomic and Precision Medicine, April 2019, Wolters Kluwer Health

     Professor Marek Sanak, Marie-Pierre Dubé

209. 
     Lipoprotein (a), arterial inflammation, and PCSK9 inhibition

     Article • European Heart Journal, March 2019, Oxford University Press (OUP)

     Marie-Pierre Dubé

210. 
     Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution

     Article • Nature Genetics, February 2019, Springer Science + Business Media

     Marie-Pierre Dubé

211. 
     Validation of genome-wide polygenic risk scores for coronary artery disease in French Canadians

     Article • February 2019, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

212. 
     Biomarkers of dementia in obstructive sleep apnea

     Article • Sleep Medicine Reviews, December 2018, Elsevier

     Marie-Pierre Dubé

213. 
     Pharmacogenetic content of commercial genome-wide genotyping arrays

     Article • Pharmacogenomics, October 2018, Future Medicine

     Marie-Pierre Dubé

214. 
     Randomized Clinical Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype

     Article • JAMA Cardiology, September 2018, American Medical Association (AMA)

     Marie-Pierre Dubé

215. 
     Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol

     Article • Journal of the American Heart Association, August 2018, Wolters Kluwer Health

     Marie-Pierre Dubé

216. 
     Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A

     Article • Blood, July 2018, American Society of Hematology

     Marie-Pierre Dubé

217. 
     Protein-Coding Variants Implicate Novel Genes Related to Lipid Homeostasis Contributing to Body Fat Distribution

     Article • June 2018, Cold Spring Harbor Laboratory Press

     Marie-Pierre Dubé

218. 
     Sex, drugs, and heart failure: a sex-sensitive review of the evidence base behind current heart failure clinical guidelines

     Article • ESC Heart Failure, June 2018, Wiley

     Marie-Pierre Dubé

219. 
     Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study

     Article • Clinical Cardiology, May 2018, Wiley

     Marie-Pierre Dubé

220. 
     Pharmacogenomics of blood lipid regulation

     Article • Pharmacogenomics, April 2018, Future Medicine

     Marie-Pierre Dubé

221. 
     A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure

     Article • Pharmacogenomics, April 2018, Future Medicine

     Marie-Pierre Dubé

222. 
     A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention

     Article • Molecular Diagnosis & Therapy, April 2018, Springer Science + Business Media

     Marie-Pierre Dubé

223. 
     Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort

     Article • The Pharmacogenomics Journal, January 2018, Springer Science + Business Media

     Marie-Pierre Dubé

224. 
     Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

     Article • Nature Genetics, December 2017, Springer Science + Business Media

     Professor Trevor A Mori, Giovanni Veronesi, Marie-Pierre Dubé

225. 
     Polygenic determinants in extremes of high-density lipoprotein cholesterol

     Article • Journal of Lipid Research, November 2017, Elsevier

     Marie-Pierre Dubé

226. 
     Exome-wide association study of plasma lipids in >300,000 individuals

     Article • Nature Genetics, October 2017, Springer Science + Business Media

     Marie-Pierre Dubé

227. 
     Precision medicine to change the landscape of cardiovascular drug development

     Article • Expert Review of Precision Medicine and Drug Development, October 2017, Taylor & Francis

     Marie-Pierre Dubé

228. 
     Impact of Selection Bias on Estimation of Subsequent Event Risk

     Article • Circulation Cardiovascular Genetics, October 2017, Wolters Kluwer Health

     Marie-Pierre Dubé

229. 
     Identification of the genetic determinants responsible for retinal degeneration in families of Mexican descent

     Article • Ophthalmic Genetics, September 2017, Taylor & Francis

     Marie-Pierre Dubé

230. 
     Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies

     Article • Current Atherosclerosis Reports, September 2017, Springer Science + Business Media

     Marie-Pierre Dubé

231. 
     DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions

     Article • Blood, August 2017, American Society of Hematology

     Marie-Pierre Dubé

232. 
     CKing Precision in the Interpretation of Diagnostic Biomarkers

     Article • Circulation Cardiovascular Genetics, August 2017, Wolters Kluwer Health

     Marie-Pierre Dubé

233. 
     Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies

     Article • JMIR Research Protocols, May 2017, JMIR Publications Inc.

     Marie-Pierre Dubé

234. 
     Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve

     Article • Nature Communications, May 2017, Springer Science + Business Media

     Marie-Pierre Dubé

235. 
     CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction

     Article • The Pharmacogenomics Journal, April 2017, Springer Science + Business Media

     Marie-Pierre Dubé

236. 
     Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol

     Article • PLoS ONE, April 2017, PLOS

     Marie-Pierre Dubé

237. 
     CETP

     Article • Arteriosclerosis Thrombosis and Vascular Biology, March 2017, Wolters Kluwer Health

     Marie-Pierre Dubé

238. 
     Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease

     Article • Journal of the American College of Cardiology, February 2017, Elsevier

     Marie-Pierre Dubé

239. 
     Pharmacogenomic approaches to lipid-regulating trials

     Article • Current Opinion in Lipidology, December 2016, Wolters Kluwer Health

     Marie-Pierre Dubé

240. 
     Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

     Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2016, Wolters Kluwer Health

     Marie-Pierre Dubé

241. 
     Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality

     Article • Pharmacoepidemiology and Drug Safety, November 2016, Wiley

     Marie-Pierre Dubé

242. 
     Paternal Age Explains a Major Portion of De Novo Germline Mutation Rate Variability in Healthy Individuals

     Article • PLoS ONE, October 2016, PLOS

     Marie-Pierre Dubé

243. 
     A model to assess the cost–effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine

     Article • Pharmacogenomics, October 2016, Future Medicine

     Marie-Pierre Dubé

244. 
     Maximal expected benefits from lowering cholesterol in primary prevention for a high-risk population

     Article • Current Medical Research and Opinion, September 2016, Taylor & Francis

     Marie-Pierre Dubé

245. 
     Meta-analysis of genome-wide association studies of HDL cholesterol response to statins

     Article • Journal of Medical Genetics, September 2016, BMJ

     Marie-Pierre Dubé

246. 
     genipe: an automated genome-wide imputation pipeline with automatic reporting and statistical tools

     Article • Bioinformatics, August 2016, Oxford University Press (OUP)

     Marie-Pierre Dubé

247. 
     Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation

     Article • Circulation Cardiovascular Genetics, August 2016, Wolters Kluwer Health

     Marie-Pierre Dubé

248. 
     Whole-genome sequencing in French Canadians from Quebec

     Article • Human Genetics, July 2016, Springer Science + Business Media

     Marie-Pierre Dubé

249. 
     Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits

     Article • The American Journal of Human Genetics, July 2016, Elsevier

     Marie-Pierre Dubé

250. 
     Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals

     Article • The American Journal of Human Genetics, July 2016, Elsevier

     Marie-Pierre Dubé

251. 
     DNA methylation signature of human fetal alcohol spectrum disorder

     Article • Epigenetics & Chromatin, June 2016, Springer Science + Business Media

     Marie-Pierre Dubé

252. 
     Avoidance of Vitamin K−Rich Foods Is Common among Warfarin Users and Translates into Lower Usual Vitamin K Intakes

     Article • Journal of the Academy of Nutrition and Dietetics, June 2016, Elsevier

     Marie-Pierre Dubé

253. 
     Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users

     Article • Journal of Managed Care & Specialty Pharmacy, June 2016, Academy of Managed Care Pharmacy

     Marie-Pierre Dubé

254. 
     Methylomic changes during conversion to psychosis

     Article • Molecular Psychiatry, April 2016, Springer Science + Business Media

     Marie-Pierre Dubé

255. 
     Coding Variation inANGPTL4,LPL,andSVEP1and the Risk of Coronary Disease

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2016, New England Journal of Medicine (NEJM/MMS)

     Marie-Pierre Dubé

256. 
     A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials

     Article • The Pharmacogenomics Journal, March 2016, Springer Science + Business Media

     Marie-Pierre Dubé

257. 
     An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance

     Article • Thrombosis and Haemostasis, March 2016, Thieme Publishing Group

     Marie-Pierre Dubé

258. 
     Testing the role of predicted gene knockouts in human anthropometric trait variation

     Article • Human Molecular Genetics, February 2016, Oxford University Press (OUP)

     Marie-Pierre Dubé

259. 
     Resting heart rate as a predictor of aortic valve stenosis progression

     Article • International Journal of Cardiology, February 2016, Elsevier

     Marie-Pierre Dubé

260. 
     Pharmacogenomics to Revive Drug Development in Cardiovascular Disease

     Article • Cardiovascular Drugs and Therapy, January 2016, Springer Science + Business Media

     Marie-Pierre Dubé

261. 
     Calcium Signaling Pathway GenesRUNX2andCACNA1CAre Associated With Calcific Aortic Valve DiseaseCLINICAL PERSPECTIVE

     Article • Circulation Cardiovascular Genetics, November 2015, Wolters Kluwer Health

     Dr Sandra Guauque-Olarte, Marie-Pierre Dubé

262. 
     Will personalized drugs for cardiovascular disease become an option? – Defining ‘Evidence-based personalized medicine’ for its implementation and future use

     Article • Expert Opinion on Pharmacotherapy, September 2015, Informa Healthcare

     Marie-Pierre Dubé

263. 
     Impact of regular physical activity on weekly warfarin dose requirement

     Article • Journal of Thrombosis and Thrombolysis, August 2015, Springer Science + Business Media

     Marie-Pierre Dubé

264. 
     Mutation Burden of Rare Variants in Schizophrenia Candidate Genes

     Article • PLoS ONE, June 2015, PLOS

     Marie-Pierre Dubé

265. 
     Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review

     Article • Pharmacogenomics, May 2015, Future Medicine

     Marie-Pierre Dubé

266. 
     Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice

     Article • International Journal of Cardiology, April 2015, Elsevier

     Marie-Pierre Dubé

267. 
     Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

     Article • Circulation Cardiovascular Genetics, April 2015, Wolters Kluwer Health

     Marie-Pierre Dubé

268. 
     Comparison of Sequencing Based CNV Discovery Methods Using Monozygotic Twin Quartets

     Article • PLoS ONE, March 2015, PLOS

     Marie-Pierre Dubé

269. 
     CKM and LILRB5 Are Associated With Serum Levels of Creatine Kinase

     Article • Circulation Cardiovascular Genetics, December 2014, Wolters Kluwer Health

     Marie-Pierre Dubé

270. 
     Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

     Article • Nature Communications, October 2014, Springer Science + Business Media

     Professor Janusz Antoni Jankowski, Marie-Pierre Dubé

271. 
     Genetic Markers of Cisplatin-Induced Hearing Loss in Children

     Article • Clinical Pharmacology & Therapeutics, September 2014, Springer Science + Business Media

     Marie-Pierre Dubé

272. 
     Modifiers of (CAG)n instability in Machado–Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes

     Article • Human Genetics, July 2014, Springer Science + Business Media

     Jorge Sequeiros, Marie-Pierre Dubé

273. 
     Development of a broad-based ADME panel for use in pharmacogenomic studies

     Article • Pharmacogenomics, July 2014, Future Medicine

     Marie-Pierre Dubé

274. 
     Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis

     Article • Circulation Cardiovascular Genetics, June 2014, Wolters Kluwer Health

     Marie-Pierre Dubé

275. 
     Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer’s Disease

     Article • Neuroscience, June 2014, Elsevier

     Marie-Pierre Dubé

276. 
     Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits

     Article • Nature Genetics, April 2014, Springer Science + Business Media

     Marie-Pierre Dubé

277. 
     Novel Mutations in the Amyloid Precursor Protein Gene within Moroccan Patients with Alzheimer's Disease

     Article • Journal of Molecular Neuroscience, March 2014, Springer Science + Business Media

     Marie-Pierre Dubé

278. 
     Comparison of genotype clustering tools with rare variants

     Article • BMC Bioinformatics, February 2014, Springer Science + Business Media

     Marie-Pierre Dubé

279. 
     Cuckoo search epistasis: a new method for exploring significant genetic interactions

     Article • Heredity, February 2014, Springer Science + Business Media

     Marie-Pierre Dubé

280. 
     Validation of patient-reported warfarin dose in a prospective incident cohort study

     Article • Pharmacoepidemiology and Drug Safety, January 2014, Wiley

     Marie-Pierre Dubé

281. 
     Evaluation of Links Between High-Density Lipoprotein Genetics, Functionality, and Aortic Valve Stenosis Risk in Humans

     Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2013, Wolters Kluwer Health

     Dr Sandra Guauque-Olarte, Marie-Pierre Dubé

282. 
     Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity

     Article • Clinical Pharmacology & Therapeutics, November 2013, Springer Science + Business Media

     Marie-Pierre Dubé

283. 
     pyGenClean: efficient tool for genetic data clean up before association testing

     Article • Bioinformatics, May 2013, Oxford University Press (OUP)

     Marie-Pierre Dubé

284. 
     Erratum: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

     Article • Nature Genetics, April 2013, Springer Science + Business Media

     Marie-Pierre Dubé

285. 
     Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent

     Article • The Pharmacogenomics Journal, April 2013, Springer Science + Business Media

     Marie-Pierre Dubé

286. 
     Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

     Article • Clinical Pharmacology & Therapeutics, April 2013, Springer Science + Business Media

     Marie-Pierre Dubé

287. 
     The Impact of Partial and Complete Loss-of-Function Mutations in Endothelial Lipase on High-Density Lipoprotein Levels and Functionality in Humans

     Article • Circulation Cardiovascular Genetics, February 2013, Wolters Kluwer Health

     Marie-Pierre Dubé

288. 
     Institutional Profile: The Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre at the Montreal Heart Institute

     Article • Pharmacogenomics, January 2013, Future Medicine

     Marie-Pierre Dubé

289. 
     SRAP Polymorphisms Associated to Cell Wall Degradability in Lignified Stems of Alfalfa

     Article • BioEnergy Research, December 2012, Springer Science + Business Media

     Marie-Pierre Dubé

290. 
     Pooled DNA Resequencing of 68 Myocardial Infarction Candidate Genes in French Canadians

     Article • Circulation Cardiovascular Genetics, October 2012, Wolters Kluwer Health

     Marie-Pierre Dubé

291. 
     Rare Copy Number Variants Contribute to Congenital Left-Sided Heart Disease

     Article • PLoS Genetics, September 2012, PLOS

     Marie-Pierre Dubé

292. 
     Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice

     Article • Physiological Genomics, September 2012, American Physiological Society

     Marie-Pierre Dubé

293. 
     Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol

     Article • PLoS ONE, August 2012, PLOS

     Marie-Pierre Dubé

294. 
     Assessment of Genetic Variability of Cell Wall Degradability for the Selection of Alfalfa with Improved Saccharification Efficiency

     Article • BioEnergy Research, May 2012, Springer Science + Business Media

     Marie-Pierre Dubé

295. 
     PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients

     Article • Pharmacogenetics and Genomics, May 2012, Wolters Kluwer Health

     Marie-Pierre Dubé

296. 
     Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

     Article • Journal of Clinical Oncology, May 2012, American Society of Clinical Oncology (ASCO)

     Marie-Pierre Dubé

297. 
     Molecular physiology and breeding at the crossroads of cold hardiness improvement

     Article • Physiologia Plantarum, April 2012, Wiley

     Marie-Pierre Dubé

298. 
     Risk of congenital heart defects is influenced by genetic variation in folate metabolism

     Article • Cardiology in the Young, April 2012, Cambridge University Press

     Marie-Pierre Dubé

299. 
     Erratum to: Intron-length polymorphism identifies a Y2K4 dehydrin variant linked to superior freezing tolerance in alfalfa

     Article • Theoretical and Applied Genetics, February 2012, Springer Science + Business Media

     Marie-Pierre Dubé

300. 
     Validation of warfarin pharmacogenetic algorithms in clinical practice

     Article • Pharmacogenomics, January 2012, Future Medicine

     Marie-Pierre Dubé

301. 
     Intron-length polymorphism identifies a Y2K4 dehydrin variant linked to superior freezing tolerance in alfalfa

     Article • Theoretical and Applied Genetics, November 2011, Springer Science + Business Media

     Marie-Pierre Dubé

302. 
     Design and rationale of a genetic cohort study on congenital cardiac disease: experiences from a multi-institutional platform in Quebec

     Article • Cardiology in the Young, July 2011, Cambridge University Press

     Marie-Pierre Dubé

303. 
     Predicting Statin Induced Muscle Toxicity

     Article • Journal of Clinical Lipidology, May 2011, Elsevier

     Marie-Pierre Dubé

304. 
     Fetal Alcohol Spectrum Disorders: Gene-Environment Interactions, Predictive Biomarkers, and the Relationship Between Structural Alterations in the Brain and Functional Outcomes

     Article • Seminars in Pediatric Neurology, March 2011, Elsevier

     Marie-Pierre Dubé

305. 
     Familial ventricular aneurysms and septal defects map to chromosome 10p15

     Article • European Heart Journal, December 2010, European Society of Cardiology

     Marie-Pierre Dubé

306. 
     Positional cloning of a quantitative trait locus contributing to pain sensitivity: possible mediation by Tyrp1

     Article • Genes Brain & Behavior, November 2010, Wiley

     Marie-Pierre Dubé

307. 
     A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura

     Article • Nature Reports Stem Cells, September 2010, Nature

     Jorge Sequeiros, Marie-Pierre Dubé

308. 
     Direct Measure of the De Novo Mutation Rate in Autism and Schizophrenia Cohorts

     Article • The American Journal of Human Genetics, September 2010, Elsevier

     Marie-Pierre Dubé

309. 
     Partitioning of copy-number genotypes in pedigrees

     Article • BMC Bioinformatics, May 2010, Springer Science + Business Media

     Marie-Pierre Dubé

310. 
     Family Study of Restless Legs Syndrome in Quebec, Canada

     Article • Archives of Neurology, May 2010, American Medical Association (AMA)

     Marie-Pierre Dubé

311. 
     Mutations in DCC Cause Congenital Mirror Movements

     Article • Science, April 2010, American Association for the Advancement of Science

     Marie-Pierre Dubé

312. 
     De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia

     Article • Proceedings of the National Academy of Sciences, April 2010, Proceedings of the National Academy of Sciences

     Marie-Pierre Dubé

313. 
     Genetic determinants of blood pressure reduction following potassium supplementation: and the candidates are…

     Article • Journal of Hypertension, April 2010, Wolters Kluwer Health

     Marie-Pierre Dubé

314. 
     Genetics of bronchopulmonary dysplasia in the age of genomics

     Article • Current Opinion in Pediatrics, April 2010, Wolters Kluwer Health

     Marie-Pierre Dubé

315. 
     Testing for Gene-Gene Interaction with AMMI Models

     Article • Statistical Applications in Genetics and Molecular Biology, January 2010, De Gruyter

     Marie-Pierre Dubé

316. 
     Novel mutations in the sacsin gene in ataxia patients from Maritime Canada

     Article • Journal of the Neurological Sciences, January 2010, Elsevier

     Marie-Pierre Dubé

317. 
     Genetic Studies

     Article • November 2009, Springer Science + Business Media

     Marie-Pierre Dubé

318. 
     Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

     Article • Nature Genetics, November 2009, Springer Science + Business Media

     Marie-Pierre Dubé

319. 
     Genetic Modulation of Brugada Syndrome by a Common Polymorphism

     Article • Journal of Cardiovascular Electrophysiology, October 2009, Wiley

     Marie-Pierre Dubé

320. 
     Application of principal component analysis to pharmacogenomic studies in Canada

     Article • The Pharmacogenomics Journal, August 2009, Springer Science + Business Media

     Marie-Pierre Dubé

321. 
     Association between cervical and intracranial dimensions and syringomyelia in the cavalier King Charles spaniel

     Article • Journal of Small Animal Practice, August 2009, Wiley

     Marie-Pierre Dubé

322. 
     Mutation in Pyrroline-5-Carboxylate Reductase 1 Gene in Families with Cutis Laxa Type 2

     Article • The American Journal of Human Genetics, July 2009, Elsevier

     Marie-Pierre Dubé

323. 
     Application of Homozygosity Haplotype Analysis to Genetic Mapping with High-Density SNP Genotype Data

     Article • PLoS ONE, April 2009, PLOS

     Marie-Pierre Dubé

324. 
     Genetic predictors of depressive symptoms in cardiac patients

     Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, April 2009, Wiley

     Marie-Pierre Dubé

325. 
     The challenge of detecting epistasis (G×G Interactions): Genetic Analysis Workshop 16

     Article • Genetic Epidemiology, January 2009, Wiley

     Marie-Pierre Dubé

326. 
     Autosomal-dominant locus for restless legs syndrome in French-Canadians on chromosome 16p12.1

     Article • Movement Disorders, October 2008, Wiley

     Marie-Pierre Dubé

327. 
     Génome Québec & Montreal Heart Institute Pharmacogenomics Centre: a translational pharmacogenomics platform – from R&D to the clinic

     Article • Pharmacogenomics, October 2008, Future Medicine

     Marie-Pierre Dubé

328. 
     Mutations in the calcium-related gene IL1RAPL1 are associated with autism

     Article • Human Molecular Genetics, September 2008, Oxford University Press (OUP)

     Marie-Pierre Dubé

329. 
     A survey of the personalized medicine landscape

     Article • Pharmacogenomics, July 2008, Future Medicine

     Marie-Pierre Dubé

330. 
     Effects of AGTR1 A1166C Gene Polymorphism in Patients with Heart Failure Treated with Candesartan

     Article • Annals of Pharmacotherapy, May 2008, SAGE Publications

     Marie-Pierre Dubé

331. 
     Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure

     Article • British Journal of Clinical Pharmacology, May 2008, Wiley

     Marie-Pierre Dubé

332. 
     A novel locus for idiopathic generalized epilepsy in French-Canadian families maps to 10p11

     Article • American Journal of Medical Genetics Part A, March 2008, Wiley

     Marie-Pierre Dubé

333. 
     No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans

     Article • Journal of Clinical Investigation, January 2008, American Society for Clinical Investigation

     Marie-Pierre Dubé

334. 
     The Genetics of Congenital Amusia (Tone Deafness): A Family-Aggregation Study

     Article • The American Journal of Human Genetics, September 2007, Elsevier

     Marie-Pierre Dubé

335. 
     Mutations in the UBIAD1 Gene, Encoding a Potential Prenyltransferase, Are Causal for Schnyder Crystalline Corneal Dystrophy

     Article • PLoS ONE, August 2007, PLOS

     Marie-Pierre Dubé

336. 
     Syringomyelia in cavalier King Charles spaniels: the relationship between syrinx dimensions and pain

     Article • Journal of Small Animal Practice, August 2007, Wiley

     Marie-Pierre Dubé

337. 
     Obesity and TCF7L2 variants' additive effect on type 2 diabetes risk in cardiac patients

     Article • Diabetes Care, June 2007, American Diabetes Association

     Marie-Pierre Dubé

338. 
     Molecular genetic studies of DMT1 on 12q in French‐Canadian restless legs syndrome patients and families

     Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, May 2007, Wiley

     Marie-Pierre Dubé

339. 
     Loss-of-function genetic diseases and the concept of pharmaceutical targets

     Article • Nature Reviews Genetics, May 2007, Springer Science + Business Media

     Marie-Pierre Dubé

340. 
     Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations

     Article • Clinical Genetics, March 2007, Wiley

     Marie-Pierre Dubé

341. 
     Lamin A/C mutations associated with familial and sporadic cases of dilated cardiomyopathy in Koreans

     Article • Experimental & Molecular Medicine, February 2007, Springer Science + Business Media

     Marie-Pierre Dubé

342. 
     Multistage designs in the genomic era: Providing balance in complex disease studies

     Article • Genetic Epidemiology, January 2007, Wiley

     Marie-Pierre Dubé

343. 
     A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13

     Article • Neurology, September 2006, Wolters Kluwer Health

     Marie-Pierre Dubé

344. 
     Bootstrap Inference with Neural-Network Modeling for Gene-Disease Association Testing

     Article • September 2006, Institute of Electrical & Electronics Engineers (IEEE)

     Marie-Pierre Dubé

345. 
     A new locus for autosomal dominant intracranial aneurysm, ANIB4, maps to chromosome 5p15.2-14.3

     Article • Journal of Medical Genetics, June 2006, BMJ

     Marie-Pierre Dubé

346. 
     Human monogenic disorders — a source of novel drug targets

     Article • Nature Reviews Genetics, March 2006, Springer Science + Business Media

     Marie-Pierre Dubé

347. 
     Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin

     Article • Psychosomatic Medicine, March 2006, Wolters Kluwer Health

     Marie-Pierre Dubé

348. 
     Autism spectrum disorders associated with X chromosome markers in French-Canadian males

     Article • Molecular Psychiatry, November 2005, Springer Science + Business Media

     Marie-Pierre Dubé

349. 
     A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I–Converting Enzyme Inhibitors

     Article • The American Journal of Human Genetics, October 2005, Elsevier

     Marie-Pierre Dubé

350. 
     Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region

     Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, March 2005, Wiley

     Marie-Pierre Dubé

351. 
     Chromosome 11-q24 region in Tourette syndrome: Association and linkage disequilibrium study in the French Canadian population

     Article • American Journal of Medical Genetics Part A, January 2005, Wiley

     Marie-Pierre Dubé

352. 
     A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease

     Article • Journal of the American College of Cardiology, October 2004, Elsevier

     Marie-Pierre Dubé

353. 
     The 14q restless legs syndrome locus in the French Canadian population

     Article • Annals of Neurology, May 2004, Wiley

     Marie-Pierre Dubé

354. 
     Identification of a Novel Gene (HSN2) Causing Hereditary Sensory and Autonomic Neuropathy Type II through the Study of Canadian Genetic Isolates

     Article • The American Journal of Human Genetics, May 2004, Elsevier

     Marie-Pierre Dubé

355. 
     Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis

     Article • Nature Genetics, November 2003, Springer Science + Business Media

     Marie-Pierre Dubé

356. 
     Article • Cancer Causes & Control, January 2003, Springer Science + Business Media

     Marie-Pierre Dubé

357. 
     AnALS2gene mutation causes hereditary spastic paraplegia in a Pakistani kindred

     Article • Annals of Neurology, December 2002, Wiley

     Marie-Pierre Dubé

358. 
     Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy

     Article • Nature Genetics, August 2002, Springer Science + Business Media

     Marie-Pierre Dubé

359. 
     Fine mapping the candidate region for peripheral neuropathy with or without agenesis of the corpus callosum in the French Canadian population

     Article • European Journal of Human Genetics, July 2002, Springer Science + Business Media

     Marie-Pierre Dubé

360. 
     Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

     Article • Pharmacogenetics, October 2001, Wolters Kluwer Health

     Marie-Pierre Dubé

361. 
     Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping

     Article • European Journal of Human Genetics, May 2000, Springer Science + Business Media

     Marie-Pierre Dubé

362. 
     Genomic structure of the human GT334 (EHOC-1) gene mapping to 21q22.3

     Article • Gene, October 1997, Elsevier

     Marie-Pierre Dubé